Everything you need to win Tonix Pharmaceuticals Holding Corp — in one platform.
Who to reach, what to say, and why now on Tonix Pharmaceuticals Holding Corp — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Tonix Pharmaceuticals Holding Corp — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals
Oct 17, 2024•over 1 year ago
Contract Type
contract
Chatham
Description
Tonix Pharmaceuticals Holding Corp. received its first payment from the U.S. Department of Defense to develop small molecule broad-spectrum antiviral agents for the prevention or treatment of infections, providing important validation and substantial non-dilutive funding for the ongoing research to advance the antiviral discovery program.
Company Information
Company
Tonix Pharmaceuticals Holding Corp
Location
Chatham, Georgia, United States
About
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases.
Predictive Intelligence
Strategic
ML-powered predictions for Tonix Pharmaceuticals Holding Corp's next move
Chatham